Interventions for preventing oral candidiasis for patients with cancer receiving chemotherapy
Interventions for preventing oral candidiasis for patients with cancer receiving chemotherapy
Cochrane Review
7 SoF Entries
Summary of Findings
Key results and quality assessments using GRADE methodology
| Outcome | Effect | Participants | Studies | Certainty |
|---|---|---|---|---|
|
Postoperative hypersensitivity (POH) (Patient‐reported Y/N) Follow‐up: 1 week
no liner |
0.56 | - | - | Not assessed |
|
Postoperative cold response measurement (CRM) (time it took in seconds for patient to feel cold sensation) Follow‐up: 1 week
no liner |
6.0 | - | - | Not assessed |
|
Restoration failure Follow‐up: 1 year
no liner |
1.0 | - | - | Not assessed |
|
Adverse events
no liner |
nan | - | - | Not assessed |
|
Postoperative hypersensitivity (POH) (Patient‐reported Y/N) at 1 week
No liner |
0.56 | - | - | Not assessed |
|
Postoperative cold response measurement (CRM) at 1 week
No liner |
6.0 | - | - | Not assessed |
|
Restoration failure at 1 year
No liner |
1.0 | - | - | Not assessed |
GRADE Certainty of Evidence:
High
Very confident in the effect estimate
Moderate
Moderately confident in the effect estimate
Low
Limited confidence in the effect estimate
Very Low
Very little confidence in the effect estimate
Review Information
| Review ID: | CD010526 |
| Outcomes: | 7 assessed |
Related Content
Evidence Quality Distribution:
Not assessed:
7